Featured Content Wave Life Sciences Ltd. (WVE) is a biotechnology company specializing in precision medicine for genetic diseases. Wave Life Sciences focuses on developing oligonucleotide therapies, which are designed to target specific genetic mutations with high accuracy. Their innovative platform allows them to engineer therapies that precisely interact with RNA to correct or modify genetic […]
Read MoreStoke Therapeutics, Inc. (STOK) is a biotechnology company dedicated to developing innovative treatments for severe genetic diseases. The company’s unique approach focuses on RNA-based medicines that can precisely target and correct the underlying genetic causes of diseases. Stoke’s lead program, STK-001, aims to treat Dravet syndrome, a severe and progressive form of epilepsy. By leveraging […]
Read MoreFulcrum Therapeutics, Inc. (FULC) Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is in Phase 2b clinical trial for the treatment […]
Read More